RE: My overview22 Jan 2022 08:02
I think all of the below is fair.
100% agree re value. And this cements as whey prices improve (btw they got worse last night - a big jump) and the profit profile improves. Also more and more automation driving the group to be more and more efficient
Ultimately part of the beauty of ingenuity is that it turns cost centres into profit centres and then a value driver in its own right
On the register I agree and this was my point yesterday. It’s not just “look at top 7” etc. you need to know who matts mates are as they are likely the cornerstone for any deal
(Matt 22%, sofina 9%, merian 2%?, management 3-5%?)
Then if SoftBank is the buyer they have their 8% or so. This was why sofina buying pre Christmas was upsetting as then you know nothing is in play (board seat as well)
Re the ingenuity contracts they modelled this at the Q3 results
Beauty spin off will cause a re-rate. Those assets are highly rated in the US. Even the online beauty retailer in India is worth a look (nykaa)
Would love some more ingenuity wins. Anyone find it odd that the Q4 update was the first one to not include names of wins?